Exco InTouch Wins EOA for Second Year Running
Complete the form below to unlock access to ALL audio articles.
Exco InTouch has announced another success in the prestigious European Outsourcing Awards, held in Frankfurt on 26 October 2011. In the second year running that the company has received the EOA award, Exco InTouch has been honoured with the accolade of ‘Best eBusiness/IT strategy’, which recognizes Exco InTouch’s collaboration with Pfizer.
The study, which focused on new Research on Electronic Monitoring of OAB Treatment Experience (REMOTE), is the first Participatory Patient-Centred (PPC) clinical trial to be conducted.
The Phase 4 trial was facilitated with the use of proven mobile eDiary technology from Exco InTouch, enabling patients to participate regardless of location, age or proximity to site.
In order to support the success of this patient-centred, field-based study, Pfizer required a mobile technology platform offering an ease-of-use interface that provided accessibility, particularly with older patients in mind.
The familiar, light-weight and accessible nature of a regular cell phone loaded with intuitive software meant it was the natural choice for Pfizer. These ePRO diaries enabled Pfizer to interact directly with study participants in a personalized and cost-effective manner, sending reminders and motivational messages directly to the patient’s cell phone.
As a result, this improved patient compliance and retention, increasing overall data accuracy. Patients were also able to manage their own trial remotely and report results directly to a trial investigator who kept close oversight of patient eligibility and safety.
Since its inception in 2005, the EOA awards has recognized new and significant developments in contract services and rewarded successful companies for their outstanding contribution to the industry throughout the year.
Despite strong competition from multiple industry competitors, the EOA crowned Exco InTouch winners of the award for their contribution in facilitating the revolutionary study with its innovative eDiary technology and flexible, customized service.
EOA judges were impressed by the potential of the cellphone-based ePRO technology to transform how patients access and participate in clinical trials and to accelerate clinical research while improving quality.
Tim Davis, CEO of Exco InTouch comments, “It is a great honour to win an award that recognizes the collaboration between Exco InTouch and Pfizer and the integral part Exco’s leading ePRO technology played in the revolutionary study. Together we have been able to meet our joint objective to focus on innovative advancements that will accelerate clinical research through enhanced data quality and improvement in the way that patients all over the world can access clinical trials.”
